Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings
Open accessAbstract
Background The United States is in the midst of an opioid epidemic. In addition to other system-level interventions, all states have responded during the crisis by implementing prescription drug monitoring programs (PDMPs). This study examines associations between specific administrative features of PDMPs and changes in the risk of prescription opioid-related poisoning (RxORP) over time.Methods This longitudinal, observational study utilized a 'natural experiment' design to assess associations between PDMP features and risk of RxORP in a nationally-representative population of privately-insured adults from 2004 to 2014. Administrative health claims data were used to identify inpatient hospital admissions and emergency department visits related to RxORP. Generalized estimating equation Poisson regression models were used to examine associations between specific PDMP features and changes in relative risk (RR) of RxORP over time.Results In adjusted analyses, states without PDMPs experienced an average annual increase in the rate of RxORP of 9.51% over the study period, while states with operational PDMPs experienced an average annual increase of 3.17%. The increase in RR of RxORP over time in states with operational PDMPs was significantly less than increases in states without PDMPs. States with specific features, including those that monitored more schedules or required more frequent data reporting, experienced stronger protective effects on the RR of RxORP over time.Conclusion This study examined associations between specific PDMP features and RxORP rates in a nationally-representative population of privately-insured adults. Results of this study may be used as empirical evidence to guide PDMP best practices.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Prescription drug monitoring programs (PDMPs) share data across states and represent a policy tool targeted toward providers, the broadest level of intervention in the socio-ecological model.
“Prescription drug monitoring programs (PDMPs) (187) share data across states and represent a policy tool targeted toward providers, the broadest level of intervention in the socio-ecological model (188, 189).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [187]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639 · see citing works
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194 · see citing works
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,350 · see citing works
The Changing Face of Heroin Use in the United States
Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.366 · Cited by 1,169 · see citing works
Increasing deaths from opioid analgesics in the United States
Paulozzi, L. J., Budnitz, D. S., & Xi, Y. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1276 · Cited by 696 · see citing works
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
(2011) · PubMed · Cited by 640 · see citing works
CDC grand rounds: prescription drug overdoses - a U.S. epidemic.
(2012) · PubMed · Cited by 494 · see citing works
Natural Experiments in the Social Sciences: A Design-Based Approach
Dunning, T. (2012) · Thammasat University Digital Collections · Cited by 466 · see citing works
Prescription Drug Monitoring Programs and Death Rates from Drug Overdose
Paulozzi, L. J., Kilbourne, E. M., & Desai, H. A. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01062.x · Cited by 374 · see citing works
Bao, Y., Pan, Y., Taylor, A., Radakrishnan, S., Luo, F., Pincus, H. A., & Schackman, B. R. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1673 · Cited by 322 · see citing works
Patrick, S. W., Fry, C., Jones, T. F., & Buntin, M. B. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1496 · Cited by 301 · see citing works
Dowell, D., Zhang, K., Noonan, R. K., & Hockenberry, J. M. (2016) · Health Affairs · doi:10.1377/hlthaff.2016.0448 · Cited by 264 · see citing works
State Legal Restrictions and Prescription-Opioid Use among Disabled Adults
Meara, E. R., Horwitz, J. R., Powell, W., McClelland, L., Zhou, W., O’Malley, A. J., & Morden, N. E. (2016) · New England Journal of Medicine · doi:10.1056/nejmsa1514387 · Cited by 251 · see citing works
Do Prescription Monitoring Programs Impact State Trends in Opioid Abuse/Misuse?
Reifler, L. M., Droz, D. E., Bailey, J. E., Schnoll, S. H., Fant, R. V., Dart, R. C., & Bartelson, B. B. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01327.x · Cited by 243 · see citing works
Mandatory Use of Prescription Drug Monitoring Programs
Haffajee, R. L., Jena, A. B., & Weiner, S. G. (2015) · JAMA · doi:10.1001/jama.2014.18514 · Cited by 212 · see citing works
Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
Pardo, B. (2016) · Addiction · doi:10.1111/add.13741 · Cited by 174 · see citing works
Prescription Drug Monitoring and Dispensing of Prescription Opioids
Brady, J. E., Wunsch, H., DiMaggio, C. J., Lang, B. H., Giglio, J. F., & Li, G. (2014) · Public Health Reports · doi:10.1177/003335491412900207 · Cited by 164 · see citing works
Evaluating the impact of prescription drug monitoring program implementation: a scoping review
Finley, E. P., Garcia, A., Rosen, K. D., McGeary, D., Pugh, M. J., & Potter, J. S. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2354-5 · Cited by 152 · see citing works
Truven Health Analytics MarketScan Databases for Clinical Research in Colon and Rectal Surgery
Schaefer, É., Messaris, E., Hollenbeak, C. S., & Kulaylat, A. S. (2019) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0038-1673354 · Cited by 140 · see citing works
Delcher, C., Wagenaar, A. C., Goldberger, B. A., Cook, R. L., & Maldonado‐Molina, M. M. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.02.010 · Cited by 126 · see citing works
Self-citationPrescription drug monitoring programs
Finklea, K. M., Bagalman, E., & Sacco, L. N. (2015) · The Nurse Practitioner · doi:10.1097/01.npr.0000473349.17393.7b · Cited by 101 · see citing works
Performance Measures of Diagnostic Codes for Detecting Opioid Overdose in the Emergency Department
Rowe, C. L., Vittinghoff, E., Santos, G., Behar, E., Turner, C., & Coffin, P. O. (2016) · Academic Emergency Medicine · doi:10.1111/acem.13121 · Cited by 99 · see citing works
Reisman, R. M., Shenoy, P. J., Atherly, A. J., & Flowers, C. R. (2009) · Substance Abuse Research and Treatment · doi:10.4137/sart.s2345 · Cited by 93 · see citing works
Islam, M. M., & McRae, I. (2014) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-15-46 · Cited by 93 · see citing works
Curtis, L. H., Stoddard, J., Radeva, J. I., Hutchison, S., Dans, P. E., Wright, A., Woosley, R. L., & Schulman, K. A. (2006) · Health Services Research · doi:10.1111/j.1475-6773.2006.00511.x · Cited by 88 · see citing works
An Evaluation of Prescription Drug Monitoring Programs
Simeone, R. S., & Holland, L. (2006) · PsycEXTRA Dataset · doi:10.1037/e597562007-001 · Cited by 75 · see citing works
Davis, C. S., Pierce, M. W., & Dasgupta, N. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.301923 · Cited by 58 · see citing works
Reardon, J. M., Harmon, K., Schult, G. C., Staton, C. A., & Waller, A. E. (2016) · BMC Emergency Medicine · doi:10.1186/s12873-016-0075-4 · Cited by 53 · see citing works
The Influence of Multiple Copy Prescription Programs on Analgesic Utilization
Wastila, L. J., & Bishop, C. E. (1996) · Journal of Pharmaceutical Care in Pain & Symptom Control · doi:10.1300/j088v04n03_02 · Cited by 45 · see citing works
Weiss, A. J., Elixhauser, A., Barrett, M. L., Steiner, C., Bailey, M. K., & O’Malley, L. (2006) · Cited by 37 · see citing works
Overview of Four Prescription Monitoring/Review Programs in Canada
Furlan, A. D., MacDougall, P., Pellerin, D., et al. (2014) · Pain Research and Management · doi:10.1155/2014/634171 · Cited by 32 · see citing works
Impact of prescription drug-monitoring program on controlled substance prescribing in the ED
McAllister, M. W., Aaronson, P., Spillane, J., et al. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.03.036 · Cited by 32 · see citing works
Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania
Paulozzi, L. J., & Stier, D. D. (2010) · Journal of Public Health Policy · doi:10.1057/jphp.2010.27 · Cited by 31 · see citing works
Simoni‐Wastila, L., & Qian, J. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3342 · Cited by 29 · see citing works
Green, T. C., Zaller, N. D., Rich, J. D., Bowman, S., & Friedmann, P. D. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01136.x · Cited by 27 · see citing works
Owens, P. L., Barrett, M. L., Weiss, A. J., et al. (2006) · Europe PMC (PubMed Central) · Cited by 21 · see citing works
Prescription Drug Monitoring Programs
Gabay, M. P. (2015) · Hospital Pharmacy · doi:10.1310/hpj5004-277 · Cited by 15 · see citing works
The evolution of prescription drug monitoring programs
Ashburn, M. A. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4036 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rhodes, E., Wilson, M., Robinson, A., Hayden, J. A., & Asbridge, M. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4642-8 · Cited by 103 · see citing works
A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health
Wiss, D. A. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00193 · Cited by 41 · see citing works
- Authors
- Pauly, N. J., Slavova, S., Delcher, C., Freeman, P. R., & Talbert, J.
- Affiliations
- University of Kentucky (US)
- University of Florida Health (US)
- Corresponding author
- Pauly, N.J.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 184
- Pages
- 26-32
- ISSN
- 0376-8716 (ISSN-L)
- PMC
- PMC5854200
- OpenAlex
- W2783112808
- Cited by
- 63
- References
- 38
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 4 · 2021: 7 · 2020: 12 · 2019: 19 · 2018: 6
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 338 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Drug and Alcohol Dependence (acceptedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Kentucky Center for Clinical and Translational Sciences (UL1TR001998)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Keywords
- prescription drug monitoring programs, opioid epidemic, emergency department visits, hospitalization, privately insured adults
- MeSH terms
- Prescription Drug Monitoring Programs, Adult, Analgesics, Opioid, Emergency Service, Hospital, Female, Humans, Longitudinal Studies, Male, United States, Drug Overdose, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review